Vitamin D is a steroid hormone traditionally connected to phosphocalcium metabolism. The discovery of pleiotropic expression of its receptor and of the enzymes involved in its metabolism has led to the exploration of the other roles of this vitamin. The influence of vitamin D on autoimmune disease-namely, on autoimmune thyroid disease-has been widely studied. Most of the existing data support a relationship between vitamin D deficiency and a greater tendency for development and/or higher titers of antibodies linked to Hashimoto's thyroiditis, Graves' disease, and/or postpartum thyroiditis. However, there have also been some reports contradicting such relationships, thus making it difficult to establish a unanimous conclusion. Even if the existence of an association between vitamin D and autoimmune thyroid disease is assumed, it is still unclear whether it reflects a pathological mechanism, a causal relationship, or a consequence of the autoimmune process. The relationship between vitamin D's polymorphisms and this group of diseases has also been the subject of study, often with divergent results. This text presents a review of the recent literature on the relationship between vitamin D and autoimmune thyroid disease, providing an analysis of the likely involved mechanisms. Our thesis is that, due to its immunoregulatory role, vitamin D plays a minor role in conjunction with myriad other factors. In some cases, a vicious cycle is generated, thus contributing to the deficiency and aggravating the autoimmune process.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551884PMC
http://dx.doi.org/10.3390/nu12092791DOI Listing

Publication Analysis

Top Keywords

vitamin autoimmune
16
autoimmune thyroid
16
relationship vitamin
12
vitamin
9
thyroid disease
8
autoimmune process
8
autoimmune
6
thyroid
4
thyroid disease-cause
4
disease-cause consequence
4

Similar Publications

Background: Subclinical vitamin D insufficiency is frequent in both developing and developed countries. Even after rickets was eliminated in the 1930s by fortifying milk, up to 1 billion people worldwide suffer from subclinical vitamin D deficiency (VDD). Numerous noncommunicable diseases (NCDs), including depression, autoimmune illnesses, diabetes, osteoporosis, and cardiovascular disease, are linked to this deficiency.

View Article and Find Full Text PDF

Background: Type 1 diabetes (T1D) is an autoimmune disorder characterized by a complex interplay of genetic and environmental factors.

Aim: The objective of this study was to identify the risk factors associated with T1D in the southern region of Iran during the year 2022.

Methods: This research employed a case-control design involving two groups (79 individuals in each group) of healthy children and adolescents diagnosed with T1D.

View Article and Find Full Text PDF

Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis.

Front Immunol

January 2025

Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) with no definitive trigger. However, epidemiological studies indicate that environmental factors, such as infection with Epstein-Barr virus (EBV) and low vitamin D (Vit D) levels in genetically predisposed individuals, are important risk factors. One leading proposal is that EBV triggers MS via mechanisms such as molecular mimicry, where activated autoreactive B and T lymphocytes mistakenly target self-antigens.

View Article and Find Full Text PDF
Article Synopsis
  • Apoptosis, or programmed cell death, is vital for tissue balance, and its disruption is linked to diseases like cancer and neurodegenerative disorders.
  • The review explores the molecular mechanisms and signaling pathways of apoptosis, including how the tumor microenvironment affects treatment resistance in cancer.
  • It also discusses new therapeutic strategies, including natural compounds and dietary supplements, that aim to modify apoptotic processes to improve disease management and cancer treatment outcomes.
View Article and Find Full Text PDF

A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action.

Front Immunol

January 2025

Amgen Research, Amgen Inc., South San Francisco, CA, United States.

Article Synopsis
  • Tolerogenic vaccines aim to create immune tolerance specifically for disease-related antigens, offering a safer alternative to broad immunosuppression, which can lead to infections and weakened anti-tumor responses.
  • They work by promoting certain immune cells that help regulate and suppress harmful immune responses, thus targeting conditions like autoimmunity and transplant rejection.
  • The design of these vaccines varies, often involving a relevant antigen paired with a tolerogenic adjuvant that enhances their effectiveness by creating a more favorable immune response through multiple mechanisms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!